维普中文期刊产品整合服务
51篇 您的检索式:作者名="Donehower R"
    题名 作者 年代 出处 被引量
1Hypersensitivity reactions from taxol显示文摘WEISS R B DONEHOWER R C WIERNIK P H 1990J Clin Oncol1990,8,7:1
2Phase Ⅰ and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory aucte leukemia显示文摘Rowinsky EK Adjiei R Donehower RC 1994J Clin Oncol1994,12,:1
3Paclitaxel (Taxol) 显示文摘ROWINSKY R K DONEHOWER R C 1995N Engl J Med1995,332,:1
4A phase Ⅱ trial of topotecan as salvage therapy in epithelial ovarian cancer 显示文摘Armstrong DK Rowinsky EK Donehower R 1995Proc Am Soc Clin Oncol1995,14,:1
5Hypersensitivity reactions from taxol 显示文摘WEISS R B DONEHOWER R C WIERNIK P H 1990J Clin Oncol1990,8,:1
6Is HIF-1 alpha a valid therapeutic target显示文摘Pili R Donehower RC 2003J Natl Cancer Inst2003,95,:1
7Taxol : a no- vel investigational anti-microtubule agent显示文摘Rowinsky E K Cazenave L A Donehower R C 1990J Natl Canc- er Inst1990,82,15:1
8Aphase Ⅱ trial of gefitinib in patients with progressive metastatic neuroendocrine tumors:a Phase Ⅱ Consortium study显示文摘Hobday TJ Holen K Donehower R 2006J Clin Oncol2006,24,18:1
9Is HIF-1α a valid therapeutic target显示文摘Pili R Donehower RC 2003J Natl Cancer Ins2003,95,7:1
10Is HIF-1 alpha a valid therapeutic target?显示文摘Pili R Donehower RC 2003J Natl Cancer Inst2003,95,:1
11Is HIF-1 alpha a valid therapeutic target显示文摘Pili R Donehower RC 2003J Natl Cancer Inst2003,95,7:1
12Is HIF-1 a valid therapeutic target显示文摘 Donehower RC 2003J Natl Cancer Inst2003,95,:1
13Phase I and pharmacodynamic study of the topoisomerase Ⅰ - inhibitor topotecan in patients with refractory acute leukemia 显示文摘Rowinsky E KAdjiei R Donehower R C 1994J Clin Oncol1994,12,:1
14Hypersensitivity reactions from taxol 显示文摘Weiss R B Donehower R C Wiernik P H 1990J Clin Oncol1990,8,7:1
15Is HIF1zlpha a valid therapeutic target? 显示文摘Pili R Donehower RC 2003J Natl Cancer Inst2003,95,7:1
16De- velopment of polyploidization in taxol-resistant human leukemia cells in vitro 显示文摘ROBERTS J R ALLISON D C DONEHOWER R C 1990Cancer Res1990,50,3:1
17Hypersensitivity reactions from taxol显示文摘WEISS R B DONEHOWER R C WIERNIK P H 1990J Clin Oncol1990,8,7:1
18Analysis of circulating tumor DNA to confirm somatic KRAS mutations显示文摘Holdhoff M Schmidt K Donehower R 2009J Nat Cancer Inst2009,101,18:1
19Paclitaxel (Taxol)显示文摘ROWINSKY E K DONEHOWER R C 1995N Engl J Med1995,332,15:1
20MLH1 ‐silenced and non‐silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes显示文摘Lawrence A Donehower Chad J Creighton Nikolaus Schultz Eve Shinbrot Kyle Chang Preethi H Gunaratne Donna Muzny Chris Sander Stanley R Hamilton Richard A Gibbs David Wheeler 2012J Pathol2012,,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费